 |
20 Diseases |  |
17 Trials |
|
17 Trials |  |
3666 News |  |
| «12...31323334353637383940414243 |
- budesonide / Generic mfg.
Trial primary completion date: Eosinophilic Esophagitis Clinical Therapy Comparison Trial (clinicaltrials.gov) - Aug 8, 2016
P2, N=60, Recruiting, Sponsor: Baylor College of Medicine
Trial primary completion date: Mar 2016 --> Mar 2017
- ||| Nerlynx (neratinib) / Puma
Enrollment change: CONTROL: An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide (clinicaltrials.gov) - Jan 28, 2016
P2, N=120, Recruiting, Sponsor: Puma Biotechnology, Inc.
Trial primary completion date: Mar 2016 --> Mar 2017 N=70 --> 120
- Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J, Humira (adalimumab) / AbbVie, Cimzia (certolizumab pegol) / Astellas, UCB
New trial: Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease (clinicaltrials.gov) - Dec 2, 2015
P=N/A, N=90, Recruiting, Sponsor: University of Maryland
- budesonide / Generic mfg.
Trial primary completion date: Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer (clinicaltrials.gov) - Apr 27, 2015
P2, N=225, Completed, Sponsor: National Cancer Institute (NCI)
N=70 --> 120 Trial primary completion date: Sep 2011 --> Sep 2008
- budesonide / Generic mfg.
Trial termination: Treatment of Microscopic Colitis (clinicaltrials.gov) - Jan 22, 2015
P=N/A, N=105, Terminated, Sponsor: Norwegian University of Science and Technology
Trial primary completion date: Sep 2011 --> Sep 2008 Active, not recruiting --> Terminated; insufficient data quality
- ||||||| budesonide / Generic mfg.
Trial completion: Safety Study of Entocort for Children With Crohn's Disease (clinicaltrials.gov) - Oct 2, 2014
P3, N=123, Completed, Sponsor: AstraZeneca
Active, not recruiting --> Terminated; insufficient data quality Active, not recruiting --> Completed
- ||||||| budesonide / Generic mfg.
Trial completion: Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan (clinicaltrials.gov) - Sep 19, 2014
P3, N=123, Completed, Sponsor: AstraZeneca
Active, not recruiting --> Completed Active, not recruiting --> Completed
- budesonide / Generic mfg.
Phase classification, Enrollment change, Trial primary completion date: Eosinophilic Esophagitis Clinical Therapy Comparison Trial (clinicaltrials.gov) - Jul 30, 2014
P2, N=60, Recruiting, Sponsor: Baylor College of Medicine
Active, not recruiting --> Completed Phase classification: P=N/A --> P2 | N=120 --> 60 | Trial primary completion date: Mar 2015 --> Mar 2016
- ||||| budesonide / Generic mfg.
Enrollment closed: Safety Study of Entocort for Children With Crohn's Disease (clinicaltrials.gov) - Jul 15, 2014
P3, N=123, Active, not recruiting, Sponsor: AstraZeneca
Phase classification: P=N/A --> P2 | N=120 --> 60 | Trial primary completion date: Mar 2015 --> Mar 2016 Recruiting --> Active, not recruiting
- ||||| budesonide / Generic mfg.
Enrollment closed, Trial primary completion date: Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan (clinicaltrials.gov) - Jul 12, 2014
P3, N=123, Active, not recruiting, Sponsor: AstraZeneca
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2014 --> Oct 2014
- |||| budesonide / Generic mfg.
Trial primary completion date: Safety Study of Entocort for Children With Crohn's Disease (clinicaltrials.gov) - May 12, 2014
P3, N=126, Recruiting, Sponsor: AstraZeneca
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2014 --> Oct 2014 Trial primary completion date: Aug 2014 --> Nov 2014
- ||| budesonide / Generic mfg.
Trial completion date: Safety Study of Entocort for Children With Crohn's Disease (clinicaltrials.gov) - May 12, 2014
P3, N=126, Recruiting, Sponsor: AstraZeneca
Trial primary completion date: Aug 2014 --> Nov 2014 Trial completion date: Aug 2014 --> Nov 2014
- ||||||| budesonide / Generic mfg.
Trial completion: Safety and Maintenance Study of Entocort for Children With Crohn's Disease (clinicaltrials.gov) - Feb 25, 2014
P3, N=55, Completed, Sponsor: AstraZeneca
Trial completion date: Aug 2014 --> Nov 2014 Active, not recruiting --> Completed
- budesonide / Generic mfg., voriconazole / Generic mfg.
New P1 trial: Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease (clinicaltrials.gov) - Sep 23, 2013
P1, N=27, Recruiting, Sponsor: National Institutes of Health Clinical Center (CC)
- | New P2 trial: APRiCCOT: Antibiotics and Hydroxychloroquine in Crohn's (clinicaltrials.gov) - Jan 31, 2013
P2, N=100, Recruiting, Sponsor: Royal Liverpool University Hospital
- |||||| budesonide / Generic mfg.
Enrollment open: Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan (clinicaltrials.gov) - Apr 19, 2012
P3, N=110, Recruiting, Sponsor: AstraZeneca
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- budesonide / Generic mfg.
Trial termination: Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis (clinicaltrials.gov) - Mar 15, 2012
P2/3, N=16, Terminated, Sponsor: Mayo Clinic
Not yet recruiting --> Recruiting Completed --> Terminated; Study closed early, because of low enrollment.
- budesonide / Generic mfg.
Enrollment change: Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis (clinicaltrials.gov) - Mar 15, 2012
P2/3, N=16, Terminated, Sponsor: Mayo Clinic
Completed --> Terminated; Study closed early, because of low enrollment. N=30 --> 16
- |||||| budesonide / Generic mfg.
Enrollment open: Safety Study of Entocort for Children With Crohn's Disease (clinicaltrials.gov) - Feb 9, 2012
P3, N=126, Recruiting, Sponsor: AstraZeneca
N=30 --> 16 Not yet recruiting --> Recruiting
- |||||||||| budesonide / Generic mfg.
New P3 trial: Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan (clinicaltrials.gov) - Jan 19, 2012
P3, N=110, Recruiting, Sponsor: AstraZeneca
- budesonide / Generic mfg.
Trial completion: Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer (clinicaltrials.gov) - Nov 3, 2011
P2, N=225, Completed, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- |||||||||| budesonide / Generic mfg.
New P3 trial: Safety and Maintenance Study of Entocort for Children With Crohn's Disease (clinicaltrials.gov) - Oct 16, 2011
P3, N=55, Completed, Sponsor: AstraZeneca
- |||||||||| budesonide / Generic mfg.
New P3 trial: Safety Study of Entocort for Children With Crohn's Disease (clinicaltrials.gov) - Sep 28, 2011
P3, N=126, Recruiting, Sponsor: AstraZeneca
- | budesonide / Generic mfg., cabazitaxel / Generic mfg.
New P2 trial: Study to assess the efficacy of budesonide in preventing diarrhea caused by treatment with cabazitaxel (CABARESC) (EUDRACT) - Aug 7, 2011
P2, N=250, Ongoing, Sponsor: Erasmus MC-Dani